Controlling Shareholder's Stake Updated to 56.6% Following Company Offering

summarizeSummary

Moshe Arkin and M. Arkin Dermatology Ltd. updated their beneficial ownership in Sol-Gel Technologies Ltd. to 56.6% following the company's underwritten offering that closed on March 25, 2026.

check_boxKey Events

• Updated Beneficial Ownership

  Moshe Arkin and M. Arkin Dermatology Ltd. now beneficially own 1,950,113 Ordinary Shares, representing 56.60% of the company's outstanding shares.

• Post-Offering Update

  This amendment reflects the updated holdings following the closing of the Issuer's underwritten offering on March 25, 2026, which increased the total outstanding shares to 3,245,270.

auto_awesomeAnalysis

This Schedule 13D/A filing updates the beneficial ownership of Moshe Arkin, a controlling shareholder, and his entity M. Arkin Dermatology Ltd. The reported change in percentage ownership (now 56.6%) is a direct result of Sol-Gel Technologies Ltd.'s underwritten offering, which closed on March 25, 2026. While the filing itself does not represent a transaction by the reporting persons, it reflects the dilutive impact of the company's capital raise on existing shareholders, including the controlling stake. Investors should note the updated ownership structure and the context of the company's recent financing activity.